Afatinib Sequenced With Concurrent Chemotherapy and Radiation in EGFR-Mutant Non-Small Cell Lung Tumors: The ASCENT Trial
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Afatinib (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms ASCENT
- 06 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 06 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 10 Jun 2017 Biomarkers information updated